Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,400 | 25,500 | 23,100 | 40,000 | 21,300 |
| Receivables | 223,600 | 211,900 | 211,000 | 205,000 | 207,800 |
| Inventories | 160,900 | 118,500 | 155,200 | 117,500 | 135,200 |
| Income taxes - deferred | 29,700 | 42,200 | 41,800 | 37,200 | 38,400 |
| TOTAL | $494,200 | $453,400 | $483,500 | $452,300 | $450,200 |
| Non-Current Assets | |||||
| PPE Net | 76,800 | 74,600 | 74,500 | 71,500 | 70,800 |
| Intangibles | 546,100 | 554,200 | 561,200 | 507,000 | 509,000 |
| Other Non-Current Assets | 84,000 | 84,400 | 32,400 | 29,200 | 26,700 |
| TOTAL | $706,900 | $713,200 | $668,100 | $607,700 | $606,500 |
| Total Assets | $1,201,100 | $1,166,600 | $1,151,600 | $1,060,000 | $1,056,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,600 | 11,600 | 11,600 | 11,400 | 11,600 |
| Accounts payable and accrued liabilities | 97,400 | 87,200 | 71,700 | 83,300 | 80,100 |
| Accrued Expenses | 27,900 | 23,800 | 30,600 | 34,300 | 32,200 |
| TOTAL | $168,400 | $149,500 | $141,400 | $167,200 | $155,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 400,200 | 366,000 | 413,600 | 326,000 | 338,200 |
| Other Non-Current Liabilities | 89,200 | 104,400 | 56,500 | 55,700 | 60,600 |
| TOTAL | $505,800 | $494,700 | $490,800 | $395,900 | $409,400 |
| Total Liabilities | $674,200 | $644,200 | $632,200 | $563,100 | $564,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,765 | 30,734 | 30,517 | 30,455 | 30,432 |
| Common Shares | 300 | 300 | 300 | 300 | 300 |
| Retained earnings | 158,700 | 156,200 | 152,100 | 131,900 | 128,900 |
| Other shareholders' equity | 400 | 400 | 400 | 400 | -200 |
| TOTAL | $526,900 | $522,400 | $519,400 | $496,900 | $492,100 |
| Total Liabilities And Equity | $1,201,100 | $1,166,600 | $1,151,600 | $1,060,000 | $1,056,700 |